This inventor holds 4 USPTO granted patents and 12 published patent applications and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Ke Pan: Innovator in Cancer Immunotherapy
Introduction
Ke Pan is a prominent inventor based in Houston, TX, specializing in the field of cancer immunotherapy. He has made significant contributions to the development of T cell receptors that target specific cancer antigens. With a total of 4 patents, his work is paving the way for innovative treatments in oncology.
Latest Patents
Ke Pan's latest patents include groundbreaking technologies that enhance the effectiveness of cancer treatments. The first patent focuses on T cell receptors with MAGE-B2 specificity and their applications. This patent outlines methods for generating MAGE-B2 specific T cells and compositions that include engineered MAGE-B2-specific T cell receptors. Furthermore, it provides methods for treating cancer by administering these MAGE-B2-specific T cells. The second patent involves HLA-restricted VCX/Y peptides and T cell receptors. This patent presents tumor-antigen VCX/Y specific peptides and engineered VCX/Y specific T cell receptors. It also details methods for generating VCX/Y-specific immune cells and their application in cancer treatment, including the use of VCX/Y-specific peptides as a vaccine.
Career Highlights
Ke Pan is affiliated with the University of Texas System, where he conducts his research and development work. His innovative approaches to cancer treatment have garnered attention in the scientific community, contributing to advancements in immunotherapy.
Collaborations
Ke Pan collaborates with notable professionals in his field, including Cassian Yee, who is also recognized for his contributions to cancer research and immunotherapy.
Conclusion
Ke Pan's work exemplifies the potential of innovative therapies in the fight against cancer. His patents and research efforts are crucial in advancing the field of immunotherapy, offering hope for more effective cancer treatments in the future.